Plain-English translation of NCT06386887 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether intermittent fasting—eating during an 8-hour window and fasting for 16 hours on most days—might help improve how your body responds to chemotherapy for ovarian cancer. Researchers believe that what you eat, and when you eat, can affect how cancer grows and how your body handles treatment. This study will check whether this fasting approach is safe and practical for patients receiving chemotherapy.
Early research suggests that diet may influence ovarian cancer biology and how well chemotherapy works, but no one has carefully studied whether this fasting approach is safe and feasible during active cancer treatment. This trial aims to fill that gap.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either try intermittent fasting (eating during an 8-hour window and fasting for 16 hours, five days per week) during your chemotherapy, or follow standard eating guidelines. You'll have visits during your chemotherapy cycles where researchers will measure your body composition, ask about side effects and quality of life, and collect samples to study how treatment is affecting your body and gut bacteria. The study involves about 20 people total and runs alongside your regular cancer care.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
United States